JB Chemicals & Pharmaceuticals Limited has unveiled a leadership slate that bets on external experience to guide its next phase of growth. In a clearance that underscores alignment with shareholder interests, the company announced the appointment of Aman Mehta as a Director and Managing Director, alongside four other non-executive directors. The appointments were approved by shareholders through a postal ballot, signaling a strategic push to fortify governance and accelerate execution across its markets.
Aman Mehta will take on the roles of Director and Managing Director for a three-year term, with effect from January 21, 2026. Mehta comes from Torrent Pharmaceuticals Limited, where he has been a driving force behind long-term growth, strategic acquisitions, and India-market expansion. His background includes leadership across pharmaceutical and power sectors, with an Economics degree from Boston University and an MBA from Columbia, positioning him to steer JB through competitive markets and a rapidly evolving industry landscape.
The new directors joining JB Chemicals include Amal Kelshikar, Hasmukh Patel and Sudhir Menon, each named as Non-Executive Non-Independent Directors, with a further appointment of Aman Mehta as MD. Kelshikar brings 32 years of strategic planning, marketing, and licensing expertise, most recently overseeing India operations at Torrent Pharmaceuticals since 2022. Patel is a veteran with 33+ years in the industry and has risen to COO at Torrent Pharma, bringing deep-operational and manufacturing acumen. Menon, a chartered and cost accountant, has been shaping financial governance at Torrent as CFO and Executive Director, Finance, equipping JB with seasoned financial leadership. Collectively, the appointments are framed as a move to reinforce board-level oversight while adding operational and financial rigor to support JB’s growth trajectory.